About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

C.I. MEDICAL CO.,LTD., The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 25% Decrease

Thu Nov 7, 2024 3:30 pm JST Revision

3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】

Guidance Update Report

C.I. MEDICAL CO.,LTD. <3540> [TSE-S] announced a performance revision after the market closed on November 7th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 has downwardly by 31.6%, from the previous forecast of 3.62 billion yen to 2.47 billion yen (compared to 3.29 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 24.9% decrease in profit. However, the full-year consolidated net income has been revised upward by 2.5 times, from the previous forecast of 2.44 billion yen to 6.13 billion yen (compared to 2.08 billion yen in the previous period), increasing the growth rate from 17.5% to 2.9 times, reaches new record high for the first time in four terms.

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the July to December period (second half) consolidated ordinary profit has downwardly by 43.2%, from the previous forecast of 2.64 billion yen to 1.5 billion yen (compared to 1.34 billion yen in the same period of the previous year), leading to a reduction in the profit growth rate from 97.4% to 12.1%.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 Prev 25,684 2,545 2,649 1,870 37.4 － Aug 13, 2024 J-GAAP
Jul - Dec, 2024 New 43,237 1,366 1,504 5,553 111.1 － Nov 7, 2024 J-GAAP
Revision Rate +68.3% -46.3% -43.2% +197.0% +197.0%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Prev 50,000 3,528 3,620 2,447 48.9 － Feb 13, 2024 J-GAAP
Dec, 2024 New 67,553 2,349 2,475 6,130 122.6 － Nov 7, 2024 J-GAAP
Revision Rate +35.1% -33.4% -31.6% +150.5% +150.5%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 23,431 1,221 1,342 856 17.1 5.04 Feb 13, 2024 J-GAAP
Jul - Dec, 2024 Guidance 43,237 1,366 1,504 5,553 111.1 － Nov 7, 2024 J-GAAP
YoY +84.5% +11.9% +12.1% +548.7% +548.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 42,891 3,990 3,889 2,521 50.4 5.04 Feb 14, 2023 J-GAAP
Dec, 2023 45,628 2,989 3,295 2,082 41.7 5.04 Feb 13, 2024 J-GAAP
Dec, 2024 Guidance 67,553 2,349 2,475 6,130 122.6 － Nov 7, 2024 J-GAAP
YoY +48.1% -21.4% -24.9% +194.4% +194.4%

Related Articles